- Home
- / Medicon Hellas
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Medicon Hellas financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€2.3
2024-10-29
Market Capitalization
€10.2 M
2024-10-29
Revenue
€15.9 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 13.8M | 13.5M | 15.3M | 21.5M | 20.8M | 18.7M | 15.9M |
| Cost of goods sold | 3.2M | 2.1M | 3.9M | 5.7M | 5.2M | 5.2M | 5.2M |
| Gross profit | 10.7M | 11.5M | 11.5M | 16.2M | 15.9M | 13.8M | 10.8M |
| Gross profit margin, % | 77.9% | 85.3% | 75.4% | 75.3% | 76.7% | 73.6% | 68.0% |
| Operating expense total | 7.9M | 9.1M | 8.6M | 9.5M | 10.4M | 9.9M | 9.8M |
| Depreciation and amortization | 626.0K | 1.2M | 1.4M | 1.7M | 1.6M | 1.7M | 1.7M |
| EBITDA | 2.9M | 2.4M | 3.0M | 6.7M | 5.6M | 3.9M | 1.0M |
| EBITDA margin, % | 20.9% | 17.9% | 19.4% | 31.1% | 26.8% | 20.9% | 6.5% |
| EBIT | 2.3M | 1.1M | 1.6M | 5.0M | 3.8M | 2.0M | 1.6M |
| EBIT margin, % | 16.4% | 8.3% | 10.3% | 23.3% | 18.5% | 10.6% | 10.2% |
| Interest income | 2.2M | 787.0K | 227.0K | 128.0K | 152.0K | 144.0K | 413.0K |
| Interest expense | 876.0K | 367.0K | 366.0K | 352.0K | 331.0K | 891.0K | 611.0K |
| Pre tax profit | 3.6M | 1.5M | 1.5M | 4.8M | 3.7M | 1.7M | 1.6M |
| Income tax expense | 1.7M | 682.0K | 635.0K | 1.5M | 955.0K | 230.0K | 216.0K |
| Net Income | 1.9M | 846.0K | 817.0K | 3.2M | 2.7M | 1.4M | 1.3M |